ArticleHarm reduction journal2026
Willingness to use a mobile syringe service program among people who inject drugs in rural Appalachia.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRural people who use drugs face a litany of structural and psychosocial barriers to SSP utilization (e.g., unreliable transportation, stigma). Mobile SSPs may mitigate some barriers, but little is known about acceptability among rural people who use drugs and their preferences for mobile SSP design. This study examines (1) factors associated with willingness to use a mobile SSP among rural people who use drugs, and (2) their desired attributes and services.
methodsData were collected from 259 participants who inject drugs that were recruited through outreach and respondent-driven sampling (RDS) in Appalachian Kentucky. In addition to descriptive analyses, independent variables' associations with the outcome (i.e., being willing to use a mobile SSP) were estimated using generalized estimating equations. All models controlled for lifetime use of a fixed-site SSP.
resultsOverall, 59.9% (n = 155) endorsed mobile SSPs as a program they would be willing to use. People with lower income, had less reliable access to transportation, were using methamphetamine, were engaging in syringe sharing and reuse, and who had experienced more overdoses in their lifetime were more willing to use a mobile SSP than were their counterparts. Those who experienced more shame around their drug use were less likely to use a mobile SSP than those who experienced no shame. Participants were receptive to a variety of locations, unit sizes, and staffing models, but the most desired staffing and locations were clinical in nature and most preferred hours of operation were afternoon hours. DISCUSSION: Findings suggest moderate willingness to engage in mobile SSP services among this population, particularly for people who use drugs who have challenges with transportation and who are engaging in behaviors that increase risk for HIV and HCV. Mobile SSPs may increase accessibility, acceptability, and ultimately, the utilization of critical harm reduction services in Appalachia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.